I thank my right hon. Friend for that reply. Will she join me in welcoming the withdrawal by pharmaceutical companies of their court action in South Africa? Does she agree that it creates an opportunity for the UN to reaffirm the right of developing countries compulsorily to license patents where there is a national emergency so that they can have improved access to drugs, particularly to deal with opportunistic infections? However, that should be done in the context of dealing with the social and economic consequences of HIV, and not just providing medical care.